Amarillo appoints new COO and director of research

Dr Mueller will be actively involved in the development of strategic alliances and business opportunities with other companies and organizations.

Most recently, he has headed Epicenter Consulting, a New Jersey-based health care consulting firm that he founded in 2001. Previously, Dr Mueller was vice president of global marketing & medical information and technology for Aventis Pharmaceuticals. Prior to that position, he served as vice president of global marketing business and marketing services for Hoechst Marion Roussel. He was also director for global commercial development, cardiovascular and metabolism at Marion Merrell Dow.

Joseph Cummins, president and CEO of Amarillo Biosciences, said: “Peter is a dynamic and results-driven executive with extensive global experience in the pharmaceutical industry. His strong organizational skills coupled with his dedication to the achievement of strategic and tactical objectives, will greatly aid our company’s efforts to achieve FDA approval for the utilization of our low-dose interferon in the treatment of multiple medical conditions.”